Associate Director, Biostatistics Consultant – Oncology - (Remote in UK- Outside IR35)

<p></p> <p style="line-height: 1.2;"><span style="font-family: tahoma, arial, helvetica, sans-serif; font-size: 12pt;">Are you interested in working directly for a single sponsor while having the security and additional career opportunities that working for a global CRO can bring? Our team says it’s the best of both worlds….</span></p> <p style="line-height: 1.2;"><span style="font-family: tahoma, arial, helvetica, sans-serif; font-size: 12pt;">ClinChoice is searching for a <strong>Associate Director, Biostatistics Consultant  – Oncology</strong> <strong> </strong>to join one of our clients. </span></p> <h2 style="line-height: 1.2;" data-pm-slice="1 1 []"><span style="font-family: tahoma, arial, helvetica, sans-serif; font-size: 12pt;">Position Summary</span></h2> <p style="line-height: 1.2;" data-pm-slice="1 3 []"><span style="font-family: tahoma, arial, helvetica, sans-serif; font-size: 12pt;">We are seeking an experienced <strong>Associate Director, Biostatistics</strong> with strong expertise in <strong>oncology drug development and clinical trial strategy</strong>. The individual will provide strategic statistical leadership across development programs and work closely with Clinical Development, Regulatory, Medical, Commercial, and Portfolio teams.</span></p> <p style="line-height: 1.2;"><strong><span style="font-family: tahoma, arial, helvetica, sans-serif; font-size: 12pt;">The ideal candidate should have experience in:</span></strong></p> <ul> <li style="font-family: tahoma, arial, helvetica, sans-serif; font-size: 12pt;"><span style="font-family: tahoma, arial, helvetica, sans-serif; font-size: 12pt;">Selecting Trial Types: decide if a trial should be superiority, non-inferiority, or equivalence-based depending on what regulators and payers need to prove the drug beats a placebo or standard of care.</span></li> <li style="font-family: tahoma, arial, helvetica, sans-serif; font-size: 12pt;"><span style="font-family: tahoma, arial, helvetica, sans-serif; font-size: 12pt;">Endpoint Selection: define and validate primary and secondary endpoints (e.g., overall survival, biomarker response rates, quality-of-life scores) to ensure they are measurable, clinically meaningful, and statistically robust.</span></li> <li style="font-family: tahoma, arial, helvetica, sans-serif; font-size: 12pt;"><span style="font-family: tahoma, arial, helvetica, sans-serif; font-size: 12pt;">Innovative Designs: statisticians frequently design <strong>adaptive trials</strong> (e.g., seamless Phase II/III designs, group sequential designs, or biomarker-driven basket/umbrella trials) to save time and patients.</span></li> <li style="font-family: tahoma, arial, helvetica, sans-serif; font-size: 12pt;"><span style="font-family: tahoma, arial, helvetica, sans-serif; font-size: 12pt;">Sample Size & Power Calculations</span></li> <li style=&